Poultry Vaccines Market is expected to reach US$ 4.1 Billion by 2031

Live Attenuated Vaccines Segment to Contribute to Growing Poultry Vaccines Market Size During 2023–2031

According to our latest study on "Poultry Vaccines Market Forecast to 2031 – Global Analysis – Type, Technology, Dosage Form, Disease, Route of Administration, and End User," the market is expected to reach US$ 4.1 billion by 2031 from US$ 2.1 billion in 2023; it is estimated to record a CAGR of 8.6% from 2023 to 2031. The market report includes growth prospects in light of current poultry vaccines market trends and driving factors influencing the market growth. The report also emphasizes the key factors driving the market and showcases the developments of prominent players. The growing poultry industry is a crucial factor propelling the poultry vaccines market growth. However, vaccination failure and improper handling impede the market growth.

Regional Overview

Based on geography, the poultry vaccines market is primarily segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. The market in North America held the second-largest share in 2023; the US dominates the market in North America. In the US, highly pathogenic avian influenza (HPAI) A(H5) viruses have been more prevalent among aquatic birds, commercial poultry, and backyard or hobbyist flocks since January 2022. According to the statistics revealed by the US Department of Agriculture (USDA) report, in February 2022, 82.05 million birds were affected, and the HPAI virus was detected in 1,116 flocks across 48 states in the US. Among 1,116 flocks, 473 were commercial, and 643 were backyard.

The table below represents the number of flocks affected across US states:

Source: USDA and Centers for Disease Control and Prevention (CDC)

The US has a competitive advantage in the poultry industry due to abundant domestic feed resources such as soybean meal and corn. As per the US Department of Agriculture (USDA) report, total poultry sales in 2022 accounted for US$ 76.9 billion, an increase of 67% from 2021. Broiler sales increased by 60%, turkey sales by 21%, and egg sales by 122% in 2022. Among these, only broiler production increased in 2021. However, the other three poultry sectors were affected by an increase in pricing in 2022, as egg and turkey sectors were particularly affected by the HPAI outbreak. For example, benchmark prices for broilers, turkey, and eggs increased by 38.9%, 25.9%, and 138.3% from 2021 to 2022, respectively, as per the USDA report. Drastic increases in the prices of poultry products and the shutdown of production due to the growing incidence of HPAI disease resulted in huge economic losses. Therefore, the demand for poultry vaccination is expected to surge in the US to overcome the demand and supply gap and control the prices of poultry products, ultimately driving the poultry vaccine market.

Poultry Vaccines Market

Growing Poultry Industry

According to the US Department of Agriculture (USDA) report, poultry has become the most consumed livestock commodity worldwide in the past two decades, particularly in developing and emerging markets. Also, poultry is expected to remain the world's largest imported livestock commodity by volume in the next 10 years, as per the same report. The demand for poultry products and imports is rising worldwide. With rising disposable incomes, consumers shift toward purchasing animal-based poultry products comprising high content of proteins, specifically chicken. With rapid urbanization in many developing economies and emerging markets such as Southeast Asia and Sub-Saharan Africa, poultry products are an affordable option for purchase, comprise high protein content, and are more readily available as compared to other expensive meat-based products. To match the demand and supply of poultry products, several countries are focusing on domestic poultry production. These countries include the US, Brazil, the European Union (EU), and Thailand, which are also major poultry exporters. According to the Council on Foreign Relations 2024 report, the US, Brazil, the European Union, and Thailand account for 71% of the world's poultry exports in 2021. Further, from 2001 to 2021, global poultry imports rose to an average of 4% year-on-year (y-o-y), reaching 14.2 million metric ton of production in 2021. USDA projects poultry imports to reach 17.5 million metric ton by 2031. With poultry products remaining high in demand worldwide and countries focusing on domestic livestock production, the demand for vaccination is also growing. Thus, the growing poultry industry fuels the poultry vaccines market growth.

Market Opportunity

Innovative Product Launches to Accelerate Market Growth in Coming Years

• In January 2024, Boehringer Ingelheim announced launching "Vaxxilive Cocci 3," a poultry coccidiosis vaccine previously known as "Hatchpak Cocci III". VAXXILIVE COCCI 3 is a tool to prevent coccidiosis and a biological alternative to in-feed anticoccidial drugs. The vaccine stimulates the bird's natural immune response, minimizing tissue damage. The vaccine contains the same proven formula producers have to come to rely on, including three genetically stable precocious strains of the important Eimeria species that affect broilers.
• In May 2021, Boehringer Ingelheim announced the launching of "VAXXITEK HVT+IBD". The new product launch is an innovative recombinant vaccine, a single shot vaccine, ensuring life-long protection for all types of production chickens, namely broiler, layer, and breeder. The product was launched in Brazil but is now available in 100 countries globally. Further, the product is Boehringer Ingelheim's largest-selling poultry vaccine in terms of revenue, accounting for 26% of sales in the poultry franchise globally.

Therefore, such government support for mass vaccination drives and designing innovative schemes is anticipated to provide lucrative opportunities for the poultry market growth in the coming years. 

Poultry Vaccines Market, by Type:

Based on type, the poultry vaccines market analysis is carried out by considering the following subsegments: broiler and layer. The broiler subsegment held a larger poultry vaccines market share in 2023 and is anticipated to register a higher CAGR of 9.0% during the forecast period.

Poultry Vaccines Market, by Technology:

By technology, the poultry vaccines market is segmented into live attenuated vaccines, inactivated vaccines, and recombinant vaccines. The live attenuated vaccines segment dominated the market in 2023. However, the recombinant vaccines segment is anticipated to register the highest CAGR of 9.1% during the forecast period.

Poultry Vaccines Market, by Dosage Form:

By dosage form, the poultry vaccines market is segmented into liquid vaccines, freeze-dried vaccines, and dust/powder form vaccines. The liquid vaccines segment held the largest poultry vaccines market share in 2023. The same segment is anticipated to register the highest CAGR of 9.0% during the forecast period.

Poultry Vaccines Market, by Disease:

By disease, the poultry vaccines market is segmented into avian influenza, avian salmonellosis, Marek's disease, infectious bronchitis, infectious bursal disease (IBD), Newcastle disease, and others. The avian influenza segment held the largest market share in 2023. However, the same segment is anticipated to register the highest CAGR of 9.3% during the forecast period.

Poultry Vaccines Market, by Route of Administration:

By route of administration, the poultry vaccines market is segmented into drinking water (D/W), intramuscular (I/M), subcutaneous (S/C), and others. The drinking water (D/W) segment dominated the market in 2023 and the same segment is anticipated to register the highest CAGR of 9.2% during the forecast period.

Industry Developments and Future Opportunities:

In May 2021, Elanco Animal Health announced the launching of "ZoaShieldä" in the US, which offers poultry producers a proven and flexible zoalene solution that controls the spread of coccidiosis. ZoaShield provides a flexible and proven active ingredient product that can be used in multiple seasons and supports smooth operations.

Poultry Vaccines Market, by Geography:

The geographic scope of the poultry vaccines market report encompasses North America (US, Canada, and Mexico), Europe (Spain, UK, Germany, France, Italy, and Rest of Europe), Asia Pacific (South Korea, China, India, Japan, Australia, and Rest of Asia Pacific), Middle East & Africa (South Africa, Saudi Arabia, UAE, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America). Developments and launch of new drugs by several market players, along with approvals by regulatory authorities, help in the market expansion.

Apart from factors driving the market, the poultry vaccines market report emphasizes prominent players' developments. Boehringer Ingelheim International GmbH, Zoetis Inc, BIOVAC, Phibro Animal Health, Hester Biosciences Ltd, Venky's (India) Ltd, Dechra Pharmaceuticals PLC, Elanco Animal Health Inc, Merck KgaA, Ceva, Nisseiken Co Ltd, and Vaccinova AB are among the prominent players operating in the market.

Contact Us
 
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com